Psammomys obesus (sand rat), a new animal model of non-alcoholic fatty liver disease

被引:14
|
作者
Maislos, M [1 ]
Medvedovskv, V
Sztarkier, I
Yaari, A
Sikuler, E
机构
[1] Soroka UMC, Dept Med, Atherosclerosis & Metab Unit, Beer Sheva, Israel
[2] Ben Gurion Univ Negev, FOHS, IL-84105 Beer Sheva, Israel
[3] Soroka UMC, Dept Med B, Beer Sheva, Israel
[4] Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel
[5] Soroka UMC, Liver Res Lab, Beer Sheva, Israel
[6] Soroka UMC, Inst Pathol, Beer Sheva, Israel
关键词
NAFLD; animal model; Psammomys obesus; steatohepatitis;
D O I
10.1016/j.diabres.2005.09.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/aims: Non-alcoholic fatty liver disease (NAFLD) is an increasingly recognized condition that includes a spectrum of clinicopathologic conditions ranging from steatotosis to cirrhosis and liver failure. NAFLD is usually associated with features of the metabolic syndrome. No established therapies can be offered to patients with NAFLD. An appropriate animal model of NAFLD would be of help in understanding the mechanisms of the disease and in testing novel therapeutic modalities. Available animal models, such as ob/ob and db/db mice, are unsatisfactory since they show only partial resemblance to human NAFLD. Psammomys obesus (sand rat) is a well-established model of type-2 diabetes and obesity, which shares most metabolic parameters of the human metabolic syndrome. In the present study, we hypothesized that P. obesus will also show features of non-alcoholic fatty liver disease. Methods: Experimental and control animals were fed normal rat chow or either chow to which fiber (30% wheat straw) was added for 6-18 weeks. Body weight and capillary glucose were measured regularly. At sacrifice blood samples, liver and epididymal fat were obtained. Histology of the liver was blindly determined by a pathologist. Results: The experimental group showed increased body weight. liver and abdominal fat pad mass, raised plasma glucose, insulin and lipids. Also, alanine-aminotransferase (189 +/- 76 IU versus 86 +/- 26 IU; p < 0.0001) was significantly higher in the experimental than the control group. Microscopic examination of liver tissue demonstrated marked macrovesicular fat infiltration in the experimental group while it was histologicaly normal in the control animals (liver fat score 1.7 +/- 1.0 and 0.2 +/- 0.4; p < 0.0001, respectively). Conclusions: Fed a calorie-rich diet P. obesus develops a syndrome, which shares metabolic, laboratory and histopathologic characteristics compatible with human NAFLD. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [1] beta-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model
    Zigmond, Ehud
    Tayer-Shifman, Oshrat
    Lalazar, Gadi
    Ben Ya'acov, Ami
    Weksler-Zangen, Sarah
    Shasha, David
    Sklair-Levy, Miriam
    Zolotarov, Lidya
    Shalev, Zvi
    Kalman, Rony
    Ziv, Ehud
    Raz, Itamar
    Ilan, Yaron
    JOURNAL OF INFLAMMATION RESEARCH, 2014, 7 : 151 - 158
  • [2] Non-alcoholic fatty liver disease
    Maurice, James
    Manousou, Pinelopi
    CLINICAL MEDICINE, 2018, 18 (03) : 245 - 250
  • [3] A novel animal model of metabolic syndrome with non-alcoholic fatty liver disease and skin inflammation
    Kulkarni, Nagaraj M.
    Jaji, Mallikarjun S.
    Shetty, Pranesha
    Kurhe, Yeshwant V.
    Chaudhary, Shilpee
    Vijaykant, G.
    Raghul, J.
    Vishwakarma, Santosh L.
    Rajesh, B. Navin
    Mookkan, Jeyannurugan
    Krishnan, Unna Maheswari
    Narayanan, Shridhar
    PHARMACEUTICAL BIOLOGY, 2015, 53 (08) : 1110 - 1117
  • [4] What's new in non-alcoholic fatty liver disease?
    Spiers, Jessica
    Brindley, James Hallimond
    Li, Wenhao
    Alazawi, William
    FRONTLINE GASTROENTEROLOGY, 2022, 13 (E1) : E102 - E108
  • [5] Pathology of non-alcoholic fatty liver disease
    Bedossa, Pierre
    LIVER INTERNATIONAL, 2017, 37 : 85 - 89
  • [6] Treatment of Non-Alcoholic Fatty Liver Disease
    Scherer, Antonia
    Dufour, Jean-Francois
    DIGESTIVE DISEASES, 2016, 34 : 27 - 31
  • [7] Mitochondria in non-alcoholic fatty liver disease
    Simoes, Ines C. M.
    Fontes, Adriana
    Pinton, Paolo
    Zischka, Hans
    Wieckowski, Mariusz R.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2018, 95 : 93 - 99
  • [8] PEDIATRIC NON-ALCOHOLIC FATTY LIVER DISEASE
    Delvin, Edgard
    Patey, Natasha
    Dubois, Josee
    Henderson, Melanie
    Levy, Emile
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2015, 34 (01) : 3 - 12
  • [9] Paediatric non-alcoholic fatty liver disease
    Nobili, Valerio
    Pinzani, Massimo
    GUT, 2010, 59 (05) : 561 - 564
  • [10] Treatment of non-alcoholic fatty liver disease
    Takei, Yoshiyuki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 79 - 80